L.B. Bohle is one of the largest system suppliers for the pharmaceutical processing industry and related sectors

Internationally active, we focus on machinery and equipment as well as process technology and components. In addition, L.B. Bohle offer sustainable solutions for demanding production processes in batch and continuous manufacturing.

ABOUT US

Our products

Continuous Manufacturing

L.B. Bohle is the most innovative technology company in the planning and implementation of machines and processes for the pharmaceutical solids production. We offer a comprehensive product portfolio for your pharmaceutical oral solid dosage production.

Our products provide added value for your daily production guaranteeing significant cost savings and efficiency. We have the optimal machine for the following processes


  • weighing
  • wet and dry granulation
  • grinding and sieving
  • container blending
  • tablet coating
  • tablet sorting
  • product handling 

We have installed several thousand systems around the world, standing out with safety, efficiency, longevity, and resource-protecting production.

Continuous Manufacturing offers many advantages for the manufacturers of pharmaceutical solids:

Integrated processes, shorter manufacture times, more flexible production and increase of quality are only some of the advantages achieved by Continuous Manufacturing. 

L.B. Bohle create Continuous Manufacturing customized to your needs:

Our modular Continuous Manufacturing system QbCon® produces coated tablets from powder to the coated tablet through direct compression, wet granulation or dry granulation. Beside the flexible production plant, L.B. Bohle offer stand-alone systems for the continuous production of twin-screw granulation, drying, dry granulation and coating.

click the boxes to discover more

Contact us

lbbohle.com

+49 25 24 93 23-0
info@lbbohle.de

ADDRESS

L.B. Bohle Maschinen und Verfahren GmbH

Industriestraße 18
D-59320 Ennigerloh

Go to article: Home | Antibiotic AdjacentGo to article: In this issueGo to article: ContentsGo to article: SHL Company InsightGo to article: SHL MedicalGo to article: TiveGo to article: Controlant Company InsightGo to article: ControlantGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: L.B. Bohle MaschinenGo to article: L.B Bohle Company InsightGo to article: ACG WorldwideGo to article: CommentGo to article: HPV infections drop due to widespread vaccinationGo to article: Europe reports the highest prevalence of chronic cough across the 7MMGo to article: How could vaccine hesitancy affect the prevalence of hearing disorders?Go to article: Datwyler Company Insight Go to article: DatwylerGo to article: RegPakGo to article: PfeifferGo to article: In DepthGo to article: Antibiotic adjacent: the alternatives tackling AMR Go to article: Regenerative medicine: ready for the big leagues? Go to article: Human challenge trials: pandemic exit strategy or ethical nightmare?Go to article: Drug dispensing goes digitalGo to article: Could this Novartis initiative finally cure sickle cell disease?Go to article: Centessa Pharmaceuticals: forging a new path for pharma R&DGo to article: Biomax Company InsightGo to article: BiomaxGo to article: DuojectGo to article: Duoject Company InsightGo to article: In DataGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: The Solubility Company - Company Insight Go to article: The Solubility companyGo to article: MyonexGo to article: BaxterGo to article: EventsGo to article: Next issue